Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 30, 2020
Hovione announced the signing of a partnership agreement with Ligand to ramp up the production output of Captisol.
read more
Hovione announced the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.
read more
Tuesday, February 22, 2022
Hovione a provider of spray drying and particle engineering, announced a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
read more
Hovione and Ripple Therapeutics have entered into a strategic partnership to expand the use of Ripple's Epidel® platform beyond ophthalmic applications.
read more
Thursday, September 25, 2025
Hovione and Microinnova Engineering announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry.
read more
Hovione and Merrion Pharmaceuticals [ESM; MERR] announced today that they have concluded a strategic partnership directed to the use of Merrion’s patented GIPET absorption enhancing technology by Hovione clients. Hovione, an international contract ...
read more
Wednesday, March 22, 2023
Hovione and Laxxon Medical announced a collaboration to advance the use of 3D screen printing technologies for the pharma industry.
read more
Hovione, a provider of spray drying and particle engineering services, announced an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
read more
Hovione was a founding member of iBET in 1989 and has just re-joined the Instituto de Biologia Experimental e Tecnológica. In order to increase the scope and strength of its research and development programs in the areas of novel and high potential ...
read more
Hovione and Firstgene Life Sciences announced a strategic collaboration to advance Hovione’s proprietary virus-like particle drug delivery platform for the targeted treatment of Hepatocellular Carcinoma (HCC), a therapeutic indication developed by ...
read more
The House on Tuesday approved a bipartisan bill that would update regulation of harmful chemicals for the first time in nearly 40 years.
read more
Hoth Therapeutics has signed contracts with providers for production of their BioLexa therapeutic, in preparation for upcoming toxicology and clinical studies.
read more
Hoth Therapeutics, a patient-focused biopharmaceutical company, announced that it has received approval from the FDA for a protocol change in its Phase 2a clinical trial of HT-001.
read more
Wednesday, March 25, 2020
Hoth has reached an agreement with Voltron to form a joint venture entity to commence preclinical studies for the development of vaccine prospects to prevent, intercept or treat the COVID-19.
read more
Hoth has executed an agreement with Reprocell to assess the effect of the HT-003 therapeutic platform on tissue from ulcerative colitis and Crohn's disease patients.
read more